The OCA-B oncogene is upregulated by BRD4-loaded super-enhancers that interact with POU2AF1 loci and cause the development of diffuse large B-cell lymphoma (DLBCL). The gene discussed is BRD4; the disease is diffuse large B-cell lymphoma.